According to Amedisys's latest financial reports and stock price the company's current Operating Margin is 6.76%. At the end of 2021 the company had an Operating Margin of 13.09%.
Year | Operating Margin | Change |
---|---|---|
2021 | 13.09% | 22.19% |
2020 | 10.71% | 13.26% |
2019 | 9.46% | -5.5% |
2018 | 10.01% | 78.79% |
2017 | 5.60% | 20.56% |
2016 | 4.64% | 467.5% |
2015 | 0.82% | -66.25% |
2014 | 2.42% | -120.31% |
2013 | -11.93% | 66.65% |
2012 | -7.16% | -77.6% |
2011 | -31.96% | -368.19% |
2010 | 11.92% | -22.94% |
2009 | 15.47% | 16.24% |
2008 | 13.30% | -3.84% |
2007 | 13.84% | 14.03% |
2006 | 12.13% | -7.6% |
2005 | 13.13% | -10.66% |
2004 | 14.70% | 46.05% |
2003 | 10.06% | 60.4% |
2002 | 6.27% | -7.38% |
2001 | 6.77% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | 3.38% | -50.00% | ๐บ๐ธ USA |
![]() National Healthcare
NHC | 14.84% | 119.53% | ๐บ๐ธ USA |
![]() Chemed CHE | 16.37% | 142.16% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.